1. Home
  2. NUVL vs LEVI Comparison

NUVL vs LEVI Comparison

Compare NUVL & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$105.11

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Logo Levi Strauss & Co

LEVI

Levi Strauss & Co

HOLD

Current Price

$22.78

Market Cap

9.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
LEVI
Founded
2017
1853
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
9.0B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
NUVL
LEVI
Price
$105.11
$22.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
12
Target Price
$134.75
$26.92
AVG Volume (30 Days)
616.4K
3.1M
Earning Date
05-08-2026
04-07-2026
Dividend Yield
N/A
2.51%
EPS Growth
N/A
178.85
EPS
N/A
0.45
Revenue
N/A
$6,282,000,000.00
Revenue This Year
N/A
$8.64
Revenue Next Year
$1,239.49
$4.82
P/E Ratio
N/A
$49.48
Revenue Growth
N/A
N/A
52 Week Low
$63.56
$15.32
52 Week High
$113.02
$24.82

Technical Indicators

Market Signals
Indicator
NUVL
LEVI
Relative Strength Index (RSI) 55.49 63.04
Support Level $100.98 $20.80
Resistance Level $107.08 $24.82
Average True Range (ATR) 3.38 0.74
MACD 0.12 0.05
Stochastic Oscillator 67.47 57.02

Price Performance

Historical Comparison
NUVL
LEVI

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About LEVI Levi Strauss & Co

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.

Share on Social Networks: